This post is sponsored by Ximedica.
Ximedica is the knowledgeable guide for those navigating the unfamiliar process of healthcare product development. Aidan Petrie, chief innovation officer and co-founder of Ximedica, helps companies and universities bring their technologies to market using a streamlined process. This FDA-registered facilitator of innovation allows companies to focus on their technology instead of the process of turning it into a product.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Petrie said Ximedica tries to provide companies a road map for how to fund technologies and helps them be realistic about what the challenges will be. Healthcare innovators today need to understand the steps in the process to get FDA clearance. Companies tend to underestimate how long it will take and how much it will cost to bring a product to market, Petrie said.
Ximedica will release a new e-book later this year, which Petrie said will provide “enough of a road map for the people developing new technologies to get an insight on how to fund new technologies, be realistic about what the challenges will be and to give them a guidebook” to the things they need to know to bring a product to market.
